Inventor · disambiguated record
Gwen Nichols
Also filed as: NICHOLS GWEN
6 granted patents·12 pending applications·17 citations·filing 2013–2023
77Inventor score
Top patents by PatentIndex Score
18 records- 0188US9486445B2Combination therapy for proliferative disordersHOFFMANN LA ROCHE·Filed 2015·Granted Nov 8, 2016·10 cites·15 claims
- 0280US2023381215A1Novel combination treatment for acute myeloid leukemia (aml)HOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0378US9216170B2Combination therapy for proliferative disordersHOFFMANN LA ROCHE·Filed 2013·Granted Dec 22, 2015·4 cites·13 claims
- 0477US9956243B2Combination treatment for acute myeloid leukemia (AML)HOFFMANN LA ROCHE·Filed 2014·Granted May 1, 2018·2 cites·13 claims
- 0574US9657351B2MRNA-based gene expression for personalizing patient cancer therapy with an MDM2 antagonistHOFFMANN LA ROCHE·Filed 2014·Granted May 23, 2017·1 cites·16 claims
- 0672US2022031726A1Novel combination treatment for acute myeloid leukemia (aml)HOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 0768US11738003B2Method for administrationHOFFMANN LA ROCHE·Filed 2020·Granted Aug 29, 2023·0 cites·11 claims
- 0868US11382892B2Method for administrationHOFFMANN LA ROCHE·Filed 2019·Granted Jul 12, 2022·0 cites·11 claims
- 0966US2020253999A1Novel combination treatment for acute myeloid leukemia (aml)HOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1062US2016303158A1Novel combination treatment for acute myeloid leukemia (aml)HOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 1161US2019328708A1Method for administrationHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 1258US2015126575A1Method for administrationHOFFMANN LA ROCHE·Filed 2015·Application pending·0 cites
- 1356US2013245089A1Method for administrationHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1454US2014200255A1Method for administrationHIGGINS BRIAN·Filed 2014·Application pending·0 cites
- 1550US2015202182A1Method for administrationHOFFMANN LA ROCHE·Filed 2015·Application pending·0 cites
- 1643US2016129033A1Combination of ro5503781 and capecitabine for cancer therapyHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 1743US2016129034A1Combination of ro5503781, capecitabine and oxaliplantin for cancer therapyHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 1830US2017227544A1Methods for personalizing patient cancer therapy with an mdm2 antagonistHOFFMANN LA ROCHE·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gwen Nichols files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →